Pages that link to "Q43029633"
Jump to navigation
Jump to search
The following pages link to Co-infection by serologically-silent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by down-regulation of type-I interferon receptor gene expression in the liver (Q43029633):
Displaying 34 items.
- Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection (Q24815355) (← links)
- Clinical impact of occult hepatitis B virus infection in immunosuppressed patients (Q27006996) (← links)
- Molecular mechanisms underlying occult hepatitis B virus infection (Q27686923) (← links)
- Leishmania interferes with host cell signaling to devise a survival strategy (Q33781265) (← links)
- Serological and molecular expression of Hepatitis B infection in patients with chronic Hepatitis C from Tunisia, North Africa (Q34174479) (← links)
- Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapy (Q34387913) (← links)
- Occult hepatitis B. (Q34768651) (← links)
- Evolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy* (Q35293895) (← links)
- Successful treatment of activated occult hepatitis B in a non-responder chronic hepatitis C patient (Q35667068) (← links)
- Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus (Q35833159) (← links)
- Occult Hepatitis B (OBH) in Clinical Settings (Q36328982) (← links)
- Clinical impact of occult HBV infections (Q36388359) (← links)
- HBV plus HCV, HCV plus HIV, HBV plus HIV. (Q36410579) (← links)
- Prevalence of occult hepatitis B virus in plasma and peripheral blood mononuclear cell compartments of patients with chronic hepatitis C infection in tehran-iran (Q37090963) (← links)
- Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment (Q37132382) (← links)
- Dual chronic hepatitis B virus and hepatitis C virus infection (Q37466211) (← links)
- Management of patients co-infected with HBV and HCV. (Q37503341) (← links)
- Treatment of HBV/HCV coinfection (Q37694558) (← links)
- Occult Hepatitis B: Clinical Implications and Treatment Decisions (Q37798473) (← links)
- Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals (Q38805093) (← links)
- Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C. (Q38997359) (← links)
- Hepatitis B virus DNA in sera of blood donors and of patients infected with hepatitis C virus and human immunodeficiency virus (Q39785613) (← links)
- Interferon-alpha receptor 1 mRNA expression in peripheral blood mononuclear cells is associated with response to interferon-alpha therapy of patients with chronic hepatitis C. (Q42460735) (← links)
- The spectrum of HBV/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management (Q42746527) (← links)
- HBV vaccination of HCV-infected patients with occult HBV infection and anti-HBc-positive blood donors (Q42999454) (← links)
- Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus (Q45394122) (← links)
- Occult hepatitis B virus infection as a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C in whom viral eradication fails (Q45397975) (← links)
- Impact of occult hepatitis B virus infection on efficacy and prognosis of interferon-alpha therapy for patients with chronic hepatitis C. (Q45494455) (← links)
- Absence of hepatitis B virus DNA in patients with hepatitis C and non-A-E hepatitis in the State of São Paulo, Brazil (Q45556738) (← links)
- Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseases (Q45619475) (← links)
- Distribution of hepatitis B virus in the liver of chronic hepatitis C patients with occult hepatitis B virus infection (Q45723049) (← links)
- In vitro infection of human peripheral blood mononuclear cells by a defective hepatitis B virus with a deletion in the PreS1 region of the viral genome (Q45732031) (← links)
- Significance and Management of Isolated Hepatitis B Core Antibody (Anti-HBc) in HIV and HCV: Strategies in the DAA Era. (Q54249544) (← links)
- The management of chronic viral hepatitis: A Canadian consensus conference 2004. (Q55428306) (← links)